Valley Brook Capital Group Inc. Has $481,000 Holdings in Zoetis Inc. (NYSE:ZTS)

Valley Brook Capital Group Inc. grew its holdings in Zoetis Inc. (NYSE:ZTS) by 3.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,463 shares of the company’s stock after buying an additional 75 shares during the period. Valley Brook Capital Group Inc.’s holdings in Zoetis were worth $481,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Quarry LP raised its position in shares of Zoetis by 273.2% in the second quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after purchasing an additional 153 shares during the period. LRI Investments LLC acquired a new stake in Zoetis during the first quarter worth approximately $43,000. Fortitude Family Office LLC grew its position in shares of Zoetis by 1,387.5% in the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after purchasing an additional 222 shares during the last quarter. Central Valley Advisors LLC bought a new position in shares of Zoetis during the second quarter worth approximately $49,000. Finally, EdgeRock Capital LLC bought a new position in shares of Zoetis during the second quarter worth approximately $56,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ZTS has been the topic of a number of research reports. JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Stifel Nicolaus boosted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler boosted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Finally, BTIG Research increased their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Ten investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Zoetis has a consensus rating of “Buy” and a consensus price target of $221.44.

Zoetis Price Performance

Shares of ZTS traded up $0.33 during midday trading on Thursday, hitting $170.70. The company’s stock had a trading volume of 342,062 shares, compared to its average volume of 2,518,841. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The stock has a market capitalization of $77.34 billion, a price-to-earnings ratio of 32.02, a price-to-earnings-growth ratio of 2.68 and a beta of 0.90. The company’s fifty day simple moving average is $188.46 and its two-hundred day simple moving average is $179.17.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a return on equity of 52.59% and a net margin of 26.55%. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.36 earnings per share. As a group, equities analysts expect that Zoetis Inc. will post 5.91 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 1.01%. The ex-dividend date is Thursday, October 31st. Zoetis’s payout ratio is 32.33%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.